A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...
Pioneering clinical trial testing how personalised mRNA vaccines can enable the immune system to target recurring pancreatic cancer.
Cancer cachexia impacts almost 90% of people living with pancreatic cancer. Learn more about this condition in this Q&A with Nicolas Clifford, PanCAN’s manager of research and education communication.
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have found that depleting a clotting protein made by the liver could slow down pancreatic cancer. The research, ...
DC News Now on MSN
What’s Going Around | Frederick Health offering breakthrough pancreatic cancer treatment
For the first time in 30 years, there is a new FDA-approved treatment for locally advanced pancreatic cancer.
Jean Trebek, Lisa Swayze, Joan Vassos, Stephen Nichols, Jeff Mauro, Jonathan Frakes, Kitty Swink, Rosa Blasi and Many More Raise [...] READ MORE ...
The Pancreatic Cancer Action Network is holding a webinar “Nutrition and Pancreatic Cancer: Weight Loss, Enzymes and More” to talk about common nutritional challenges related to pancreatic cancer.
Depleting a clotting protein from the liver may help slow pancreatic cancer, according to a new study conducted by a team of researchers at the Indiana University Melvin and Bren Simon Comprehensive ...
Caris received FDA approval in November 2024 for MI Cancer Seek, a tissue-based assay that is the first and only simultaneous Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results